¼¼°èÀÇ À¯¹æ¾Ï ¾×ü»ý°Ë °Ë»ç ±â±â ½ÃÀå : »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø, Á¦°ø ǰ¸ñº°, ¼øÈ¯ ¹ÙÀÌ¿À¸¶Ä¿º°, ¿ëµµº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Breast Cancer Liquid Biopsy Testing Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Offerings, By Circulating Biomarker, By Application, By Region & Competition, 2020-2030F
»óǰÄÚµå : 1698054
¸®¼­Ä¡»ç : TechSci Research
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 180 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,511,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 5,500 £Ü 7,957,000
PDF and Excel (Multi-User License) help
PDF ¹× Excel º¸°í¼­¸¦ ±â¾÷ÀÇ ÆÀÀ̳ª ±â°ü¿¡¼­ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,000 £Ü 11,575,000
PDF and Excel (Custom Research License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù. 80½Ã°£ÀÇ ¾Ö³Î¸®½ºÆ® ŸÀÓÀÌ Æ÷ÇԵǾî ÀÖ°í Copy & Paste °¡´ÉÇÑ PPT ¹öÀüµµ Á¦°øµË´Ï´Ù. ªÀº Bespoke ¸®¼­Ä¡ ÇÁ·ÎÁ§Æ® ¼öÇà¿¡ ¸Â´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

À¯¹æ¾Ï ¾×ü»ý°Ë °Ë»ç ±â±â ¼¼°è ½ÃÀåÀº 2024³â 8¾ï 3,536¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È 17.20%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¾×ü»ý°ËÀº À¯¹æ¾Ï Áø´Ü ¹× Ä¡·á ¿µ¿ª¿¡¼­ ±ÍÁßÇÑ ÀÚ»êÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¾×ü»ý°ËÀ» ÅëÇÑ µ¹¿¬º¯ÀÌ ºÐ¼®Àº Á¾¾ç ƯÀÌÀû À¯ÀüÀÚ º¯È­¸¦ ±â¹ÝÀ¸·Î ȯÀÚ °³°³Àο¡ ¸Â´Â Ç¥Àû Ä¡·á¹ýÀ» ã¾Æ³»´Âµ¥ µµ¿òÀ» ÁÝ´Ï´Ù. ¿¹¸¦ µé¾î, ÀüÀ̼º À¯¹æ¾Ï ȯÀÚÀÇ °æ¿ì, HR ¾ç¼º Á¾¾çÀÇ ¾à 40%¿¡¼­ ¹ß°ßµÇ´Â PIK3CA µ¹¿¬º¯À̸¦ °Ë»çÇÏ¸é °¡Àå È¿°úÀûÀÎ Ä¡·á¹ýÀ» °áÁ¤ÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹¾ÏÇùȸ(ASC) º¸°í¼­ 2023¿¡ µû¸£¸é À¯¹æ¾ÏÀº ÇǺξÏÀ» Á¦¿ÜÇÏ°í ¹Ì±¹¿¡¼­ ¿©¼º¿¡°Ô °¡Àå ÈçÇÑ ¾ÏÀÔ´Ï´Ù. ¸Å³â Áø´ÜµÇ´Â ¸ðµç ¿©¼º ¾ÏÀÇ 30%¸¦ Â÷ÁöÇÕ´Ï´Ù. À¯¹æ¾ÏÀÇ À¯º´·ü°ú »ç¸Á·üÀ» ³·Ãß±â À§ÇØ Á¤ºÎ´Â Áø´Ü°ú Ä¡·á¿¡ µå´Â ºñ¿ëÀ» ȯÀڵ鿡°Ô Áö¿øÇÏ´Â Á¤Ã¥À» ½ÃÇàÇÏ°í ¹ý·üÀ» µµÀÔÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼¼°èº¸°Ç±â±¸(WHO)ÀÇ 2023³â º¸°í¼­¿¡ µû¸£¸é, À¯¹æ¾ÏÀº ¿¬°£ 230¸¸ ¸í ÀÌ»óÀÇ È¯ÀÚ°¡ Áø´Ü¹Þ°í ÀÖÀ¸¸ç, ¼ºÀο¡¼­ °¡Àå ¹ßº´·üÀÌ ³ôÀº ¾ÏÀÔ´Ï´Ù. ±×·¯³ª À¯¹æ¾Ï °ü·Ã »ç¸ÁÀÇ ¾à 80%´Â ÁßÀú¼Òµæ ±¹°¡¿¡¼­ ¹ß»ýÇÕ´Ï´Ù.

½ÃÀå °³¿ä
¿¹Ãø ±â°£ 2026-2030³â
½ÃÀå ±Ô¸ð : 2024³â 8¾ï 3,536¸¸ ´Þ·¯
½ÃÀå ±Ô¸ð : 2030³â 21¾ï 4,906¸¸ ´Þ·¯
CAGR : 2025-2030³â 17.20%
±Þ¼ºÀå ºÎ¹® ¼øÈ¯ Á¾¾ç DNA
ÃÖ´ë ½ÃÀå ºÏ¹Ì

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

¾Ï °¨Áö ±â¼úÀÇ ¹ßÀü

ÁÖ¿ä ½ÃÀå À̽´

Á¦ÇÑµÈ °¨µµ¿Í ƯÀ̼º

ÁÖ¿ä ½ÃÀå µ¿Çâ

±âÁ¸ Áø´Ü¹ý°úÀÇ ÅëÇÕ

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå °í°´ÀÇ ¼Ò¸®

Á¦5Àå ¼¼°èÀÇ À¯¹æ¾Ï ¾×ü»ý°Ë °Ë»ç ±â±â ½ÃÀå Àü¸Á

Á¦6Àå ºÏ¹ÌÀÇ À¯¹æ¾Ï ¾×ü»ý°Ë °Ë»ç ±â±â ½ÃÀå Àü¸Á

Á¦7Àå À¯·´ÀÇ À¯¹æ¾Ï ¾×ü»ý°Ë °Ë»ç ±â±â ½ÃÀå Àü¸Á

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ À¯¹æ¾Ï ¾×ü»ý°Ë °Ë»ç ±â±â ½ÃÀå Àü¸Á

Á¦9Àå ³²¹ÌÀÇ À¯¹æ¾Ï ¾×ü»ý°Ë °Ë»ç ±â±â ½ÃÀå Àü¸Á

Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ À¯¹æ¾Ï ¾×ü»ý°Ë °Ë»ç ±â±â ½ÃÀå Àü¸Á

Á¦11Àå ½ÃÀå ¿ªÇÐ

Á¦12Àå ½ÃÀå µ¿Çâ°ú ¹ßÀü

Á¦13Àå PorterÀÇ Five Forces ºÐ¼®

Á¦14Àå °æÀï ±¸µµ

Á¦15Àå Àü·«Àû Á¦¾È

Á¦16Àå ¸®¼­Ä¡»ç¿¡ ´ëÇØ & ¸éÃ¥»çÇ×

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Breast Cancer Liquid Biopsy Testing Devices Market was valued at USD 835.36 million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 17.20% through 2030. Liquid biopsy serves as a valuable asset in the realm of breast cancer diagnosis and treatment. The analysis of mutations through liquid biopsy aids in the identification of targeted therapies tailored to individual patients based on their tumor-specific genetic alterations. To illustrate, in the case of patients grappling with metastatic breast cancer, screening for the PIK3CA mutation, which is found in around 40% of HR-positive tumors, assists in determining the most effective treatment path. For instance, according to the American Society of Cancer (ASC) Report 2023, breast cancer remains the most common cancer among women in the United States, excluding skin cancers. It accounts for 30% of all female cancers diagnosed annually. In an effort to reduce the prevalence and mortality rates of breast cancer, the government has implemented policies and introduced laws to support patients with the costs of diagnosis and treatment. Also, according to the World Health Organization 2023 report, more than 2.3 million cases of breast cancer are diagnosed annually, making it the most prevalent cancer among adults. However, approximately 80% of breast cancer-related deaths occur in low- and middle-income countries.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 835.36 Million
Market Size 2030USD 2149.06 Million
CAGR 2025-203017.20%
Fastest Growing SegmentCirculating Tumor DNA
Largest MarketNorth America

Key Market Drivers

Advancements in Cancer Detection Technology

The landscape of cancer detection and diagnosis is evolving rapidly, and one area of remarkable progress is the development of liquid biopsy testing devices. These devices, which have gained prominence in the healthcare industry, are offering a non-invasive, highly sensitive, and patient-friendly approach to detect and monitor cancer, with breast cancer being a significant focus.

One of the keyways advancements in cancer detection technology are boosting the growth of the global breast cancer liquid biopsy market is by enhancing sensitivity and specificity. Liquid biopsies can now detect minute traces of circulating tumor DNA (ctDNA) or other biomarkers in a patient's bloodstream. This increased sensitivity ensures that even small tumors or minimal residual disease (MRD) can be detected accurately, which was often challenging with traditional diagnostic methods.

Key Market Challenges

Limited Sensitivity and Specificity

While liquid biopsy testing devices have advanced considerably, they may still face challenges related to sensitivity and specificity. Detecting circulating tumor DNA (ctDNA) or other biomarkers in the bloodstream can be challenging, especially for small or early-stage tumors. Improving the sensitivity and specificity of these tests remains a priority for the industry.

Key Market Trends

Integration with Conventional Diagnostics

The trend is moving towards the integration of liquid biopsy testing devices with traditional diagnostic methods. Combining liquid biopsies with imaging and tissue biopsies can provide a more comprehensive understanding of the disease. This integrated approach offers greater diagnostic accuracy and opens up new avenues for treatment decisions.

Key Market Players

Report Scope:

In this report, the Global Breast Cancer Liquid Biopsy Testing Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Breast Cancer Liquid Biopsy Testing Devices Market, By Offerings:

Breast Cancer Liquid Biopsy Testing Devices Market, By Circulating Biomarker:

Breast Cancer Liquid Biopsy Testing Devices Market, By Application:

Breast Cancer Liquid Biopsy Testing Devices Market, By Region:

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Breast Cancer Liquid Biopsy Testing Devices Market.

Available Customizations:

Global Breast Cancer Liquid Biopsy Testing Devices market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Breast Cancer Liquid Biopsy Testing Devices Market Outlook

6. North America Breast Cancer Liquid Biopsy Testing Devices Market Outlook

7. Europe Breast Cancer Liquid Biopsy Testing Devices Market Outlook

8. Asia-Pacific Breast Cancer Liquid Biopsy Testing Devices Market Outlook

9. South America Breast Cancer Liquid Biopsy Testing Devices Market Outlook

10. Middle East and Africa Breast Cancer Liquid Biopsy Testing Devices Market Outlook

11. Market Dynamics

12. Market Trends & Developments

13. Porter's Five Forces Analysis

14. Competitive Landscape

15. Strategic Recommendations

16. About Us & Disclaimer

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â